LUF8100 is a dual-target antagonist of CCR2/CCR5 with pKi values for CCR2 and CCR5 of 5.23 and 4.97 respectively. LUF8100 can be used for research on immune homeostasis and cancer[1].
Molecular Weight:
418.86
CAS Number:
[2954281-30-0]
Formula:
C18H18ClF3N2O2S
Target:
CCR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
